Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management-Reference-Cited by-同舟云学术

Novel Dual-Target μ-Opioid Receptor and Dopamine D3 Receptor Ligands as Potential Nonaddictive Pharmacotherapeutics for Pain Management

Published:2021-05-20 Issue:11 Volume:64 Page:7778-7808
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Bonifazi Alessandro¹^ORCID,Battiti Francisco O.¹,Sanchez Julie²³,Zaidi Saheem A.⁴,Bow Eric⁵,Makarova Mariia⁵,Cao Jianjing¹,Shaik Anver Basha¹^ORCID,Sulima Agnieszka⁵,Rice Kenner C.⁵,Katritch Vsevolod⁴^ORCID,Canals Meritxell²³^ORCID,Lane J. Robert²³^ORCID,Newman Amy Hauck¹^ORCID

Affiliation:

1. Medicinal Chemistry Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, 333 Cassell Drive, Baltimore, Maryland 21224, United States

2. Division of Physiology, Pharmacology and Neuroscience, School of Life Sciences, Queen’s Medical Centre, University of Nottingham, Nottingham NG7 2UH, U.K.

3. Centre of Membrane Protein and Receptors, Universities of Birmingham and Nottingham, Midlands NG2 7AG, U.K.

4. Bridge Institute, Michelson Center for Convergent Bioscience, Department of Chemistry, Department of Biological Sciences, University of Southern California, Los Angeles, California 90089, United States

5. Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, National Institute on Drug Abuse—Intramural Research Program, National Institutes of Health, 9800 Medical Center Drive, Bethesda, Maryland 20892, United States

Funder

National Institute on Drug Abuse

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00611

Reference69 articles.

1. CDC/NCHS National Vital Statistics System, Mortality. CDC WONDER; US Department of Health and Human Services, CDC: Atlanta, GA. https://www.cdc.gov/nchs/nvss/deaths.htm (accessed Feb 10, 2021).

2. Roy, L. https://www.forbes.com/sites/lipiroy/2020/05/23/collision-of-crises-how-covid-19-will-propel-drug-overdose-from-bad-to-worse/#5cbc00837d3a (accessed Feb 10, 2021).

3. The Escalation of the Opioid Epidemic Due to COVID-19 and Resulting Lessons About Treatment Alternatives

4. NIH/NIDA. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-overdose-crisis (accessed Feb 10, 2021).

5. Rates of opioid misuse, abuse, and addiction in chronic pain

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Haloperidol for Pain Management: A Narrative Review;Pharmaceuticals;2024-08-21

2. Systematic Structure–Activity Relationship Study of Nalfurafine Analogues toward Development of Potentially Nonaddictive Pain Management Treatments;Journal of Medicinal Chemistry;2024-05-30

3. In Vitro and In Vivo Pharmacological Profiles of LENART01, a Dermorphin–Ranatensin Hybrid Peptide;International Journal of Molecular Sciences;2024-04-03

4. Regio‐ and Enantioselective Synthesis of Succinimides Bearing All‐Carbon Quaternary Centers Using a Chiral Phenanthroline‐Palladium Catalyst;Advanced Synthesis & Catalysis;2024-03-27

5. Pharmacological and Physicochemical Properties Optimization for Dual-Target Dopamine D₃ (D₃R) and μ-Opioid (MOR) Receptor Ligands as Potentially Safer Analgesics;Journal of Medicinal Chemistry;2023-07-19